Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2017-001406-15Phase 4Active
Phase 4 trial of moxifloxacin in community-acquired pneumonia (CAP) (2 arms), sponsored by Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer. Primary endpoint: Rate of treatment failure during the first 30 days after hospital admission. Started Apr 2018; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2017-001406-15.